Company: PTPI
Filing Date: 2025-01-24
Form Type: S-1
Source: 0001410578-25-000047
Chunk: 182

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-01-24
Form: S-1
Chunk 182
---
 | ​ | —      | ​ | —      | ​ | —            | ​ | —            | ​ | —            | ​ |    30,000 | ​ |

| (1) | Based upon the number of options issued times Black-Scholes value. |

| (2) | Mr. Shulman resigned from his role as director of the Company, effective as of October 1, 2024. |

| (3) | Mr. Bradley resigned from his role as director of the Company, effective as of October 2, 2024. |

For each fiscal year, each non-employee director, other than the Chairman and Vice Chairman, will receive an annual cash retainer in the amount of $60,000, and the Vice Chairman will receive an annual cash retainer in the amount of $200,000 per year. In the event of a Change in Control (as defined in the Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan (as amended, the “2020 Plan”)), shares of common stock of the Company underlying each of the restricted stock units granted to any non-employee director and the Initial Grant, along with any other stock options or equity-based awards held by any non-employee director, either (i) shall be assumed by, or replaced with grants of comparable awards of, the surviving entity or (ii) will vest and become exercisable, as applicable, immediately prior to such Change in Control, unless otherwise provided in the applicable award agreement. Compensation Committee Interlocks and Insider Participation The Compensation Committee consists of Mr. Silverman, as Chairman, Mr. Bernstein and Mr. Walker. No member of the Compensation Committee has been an officer or employee of the Company. None of our executive officers serves on the board of directors or compensation committee of a company that has an executive officer that serves on our Board or Compensation Committee.

110

PRINCIPAL STOCKHOLDERS The following table sets forth information with respect to the beneficial ownership of our voting securities as of January 22, 2025, by each stockholder known by us to be the beneficial owner of more than 5% of our voting securities and each of our directors and named executive officers. We have determined beneficial ownership in accordance with the rules of the SEC, which generally means that a person has beneficial ownership of a security if he or she possesses sole or shared voting or investment power of that security, including options that are currently exercisable or are exercisable